Skip to content

POP Pharma

Active
Private limited companyfounded 2010active for 15 yearsWeverstraat 1, 1741 Ternat, BelgiumKBO/BCE: BE 0831.101.641

From the official registers: KBO 15 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

POP Pharma has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €962,646 and a net result of €269,974. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 91% of 22,679 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

History

POP Pharma was incorporated on 16 November 2010.1 Total assets went from €1.2m in 2018 to €1.1m in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
29-06
NBB filing Annual accounts filedNBB
financial year 2025 · micro format
2025
31-12
Financial Highest result from 2018 to 2025net €269,974 ▲125%
Net result €269,974, the highest in the series.
28-08
NBB filing Annual accounts filedPDF
financial year 2024 · micro format · 28 days late
2024
01-07
NBB filing Annual accounts filedPDF
financial year 2023 · micro format
2023
14-12
Gazette deed Resignations: POPPE Geert (director) and DE DOBBELEER Kristien (director)
Reappointments: POPPE Geert (director) and DE DOBBELEER Kristien (director) · Registered office clause · Amendment of the articles14 facts ▸
  • Director resignation, POPPE Geert (director)
  • Director resignation, DE DOBBELEER Kristien (director)
  • Director reappointment, POPPE Geert (director (not named in the articles))
  • Director reappointment, DE DOBBELEER Kristien (director (not named in the articles))
  • Other provision, “uitoefening mandaat, Kwijting ontslagnemende bestuurders” (deed in Dutch)
  • Registered office clause, “1741 Wambeek,Weverstraat 1” (deed in Dutch)
  • General meeting, 01-12-2023
  • Other provision, “BE0831.101.641, identificatie en voorgeschiedenis” (deed in Dutch)
  • Amendment of the articles (3 times)
  • Capital conversion, “statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Other provision, “vormen en meerderheden van statutenwijziging, opheffing statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
  • Other provision, “uitkering uit winst lopende boekjaar of winst voorgaande boekjaar zolang jaarrekening nog niet goedgekeurd, interimdividend” (deed in Dutch)
  • +2 further facts in this act

Open the act in the Belgian Official Gazette

30-08
NBB filing Annual accounts filedPDF
financial year 2022 · micro format · 30 days late
2022
27-09
NBB filing Annual accounts filedPDF
financial year 2021 · micro format · 58 days late
2021
01-07
NBB filing Annual accounts filedPDF
financial year 2020 · abbreviated format
2020
31-12
Financial Equity above €500,000equity €553,513 ▲11.9%
A profit in every financial year since 2018 builds equity to €553,513.
27-08
NBB filing Annual accounts filedPDF
financial year 2019 · abbreviated format · 27 days late
26-08
NBB filing Annual accounts filedPDF
financial year 2018 · abbreviated format · 392 days late
2018
29-06
NBB filing Annual accounts filedPDF
financial year 2017 · abbreviated format
2017
21-06
NBB filing Annual accounts filedPDF
financial year 2016 · abbreviated format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank